Silco Pharmaceuticals Limited (DSE: SILCOPHL)
Bangladesh
· Delayed Price · Currency is BDT 15.90
-0.10 (-0.62%)
At close: Jan 28, 2025
Silco Pharmaceuticals Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Net Income | 52.06 | 45.88 | 69.22 | 84.45 | 84.65 | 83.18 | Upgrade
|
| Depreciation & Amortization | 93.22 | 93.22 | 90.53 | 78.49 | 78.4 | 78.69 | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.72 | 0.72 | -18.56 | -6.48 | -0.42 | - | Upgrade
|
| Other Operating Activities | 9.28 | 7.67 | 13.22 | 16.77 | -9.2 | 22.4 | Upgrade
|
| Change in Accounts Receivable | -42.09 | -42.09 | 11.73 | 1.3 | 94.46 | 5 | Upgrade
|
| Change in Inventory | 0.05 | 0.05 | 13.7 | -8.39 | 5.26 | -28.68 | Upgrade
|
| Change in Accounts Payable | -0.15 | -0.15 | -2.58 | -3.82 | -2.7 | 0.68 | Upgrade
|
| Change in Other Net Operating Assets | -20.98 | -20.98 | 3.22 | 6.76 | 6.77 | -14.65 | Upgrade
|
| Operating Cash Flow | 92.11 | 84.31 | 180.48 | 169.08 | 257.21 | 146.61 | Upgrade
|
| Operating Cash Flow Growth | -40.89% | -53.29% | 6.74% | -34.26% | 75.44% | 81.52% | Upgrade
|
| Capital Expenditures | -99.3 | -84.26 | -181.95 | -106.13 | -376.43 | -170.05 | Upgrade
|
| Investment in Securities | 0.92 | 22.96 | 22.71 | -28.81 | 136.17 | -5.95 | Upgrade
|
| Other Investing Activities | 3.47 | -0.72 | 18.56 | 6.48 | 0.42 | 0 | Upgrade
|
| Investing Cash Flow | -94.92 | -62.01 | -140.68 | -128.47 | -239.83 | -176.01 | Upgrade
|
| Long-Term Debt Repaid | - | -4.3 | -4.11 | -3.77 | -3.54 | - | Upgrade
|
| Net Debt Issued (Repaid) | -4.29 | -4.3 | -4.11 | -3.77 | -3.54 | - | Upgrade
|
| Common Dividends Paid | -19.25 | -19.14 | -31.45 | -62.62 | -62.01 | -18.39 | Upgrade
|
| Other Financing Activities | -0.93 | -0.93 | -0.2 | -0.53 | -0.76 | -1.96 | Upgrade
|
| Financing Cash Flow | -24.48 | -24.37 | -35.76 | -66.93 | -66.31 | -20.35 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -0 | - | 0 | -0 | 0 | - | Upgrade
|
| Net Cash Flow | -27.29 | -2.06 | 4.05 | -26.31 | -48.94 | -49.75 | Upgrade
|
| Free Cash Flow | -7.19 | 0.05 | -1.47 | 62.95 | -119.22 | -23.45 | Upgrade
|
| Free Cash Flow Margin | -1.70% | 0.01% | -0.32% | 11.25% | -19.83% | -3.20% | Upgrade
|
| Free Cash Flow Per Share | -0.07 | 0.00 | -0.01 | 0.61 | -1.15 | -0.23 | Upgrade
|
| Cash Interest Paid | 0.93 | 0.93 | 0.2 | 0.53 | 0.76 | - | Upgrade
|
| Cash Income Tax Paid | 7.88 | 6.73 | 6.99 | 8.27 | 14.95 | 5.32 | Upgrade
|
| Levered Free Cash Flow | -20.38 | -13.19 | -11.75 | 36.24 | -142.51 | -52.35 | Upgrade
|
| Unlevered Free Cash Flow | -19.72 | -12.54 | -11.55 | 36.57 | -142.03 | -52.35 | Upgrade
|
| Change in Net Working Capital | 52.94 | 58.49 | -37.89 | -3.28 | -106.37 | 21.59 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.